Does fixed dose combination anti-tuberculosis therapy improve treatment outcomes? A systematic review and meta-analysis
Background: Fixed dose combination (FDC) anti-tuberculosis (TB) therapy is currently recommended to facilitate patient adherence, and prevent inadvertent or intentional mono-therapy. We have conducted a systematic review to evaluate the risk of treatment failure or relapse and acquired drug resistan...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en |
| Published: |
McGill University
2013
|
| Subjects: | |
| Online Access: | http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=114407 |